
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11469726
[patent_doc_number] => 20170056509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'HYALURONIC ACID MODIFIED BY SPHINGOSINE-1-PHOSPHORIC ACID'
[patent_app_type] => utility
[patent_app_number] => 15/123359
[patent_app_country] => US
[patent_app_date] => 2015-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4754
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15123359
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/123359 | Hyaluronic acid modified by sphingosine-1-phosphoric acid | Mar 4, 2015 | Issued |
Array
(
[id] => 11290513
[patent_doc_number] => 20160340445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'ORALLY AVAILABLE COMPOUNDS, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS ANTI-ADHESIVE DRUGS FOR TREATING E. COLI INDUCED INFLAMMATORY BOWEL DISEASES SUCH AS CROHN\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/113986
[patent_app_country] => US
[patent_app_date] => 2015-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 35720
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/113986 | Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating | Jan 22, 2015 | Issued |
Array
(
[id] => 14003255
[patent_doc_number] => 10220055
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Composition effective against viral conjunctivitis
[patent_app_type] => utility
[patent_app_number] => 15/112778
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6117
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15112778
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/112778 | Composition effective against viral conjunctivitis | Jan 19, 2015 | Issued |
Array
(
[id] => 11311758
[patent_doc_number] => 20160347868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'FUC3S4S SUBSTITUTED OLIGOGLYCOSAMINOGLYCAN AND PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/110664
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17418
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110664
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/110664 | Fuc3S4S substituted oligoglycosaminoglycan and preparation method thereof | Dec 18, 2014 | Issued |
Array
(
[id] => 13300315
[patent_doc_number] => 20180201694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => CHITIN DERIVATIVES, METHOD FOR PRODUCTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/105153
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105153
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/105153 | CHITIN DERIVATIVES, METHOD FOR PRODUCTION AND USES THEREOF | Dec 15, 2014 | Abandoned |
Array
(
[id] => 17451935
[patent_doc_number] => 11266772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Use of heparin and carbohydrates to treat cancer
[patent_app_type] => utility
[patent_app_number] => 14/565387
[patent_app_country] => US
[patent_app_date] => 2014-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6157
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14565387
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/565387 | Use of heparin and carbohydrates to treat cancer | Dec 8, 2014 | Issued |
Array
(
[id] => 14357791
[patent_doc_number] => 10300176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Catheter lock solution formulations
[patent_app_type] => utility
[patent_app_number] => 14/554018
[patent_app_country] => US
[patent_app_date] => 2014-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3423
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14554018
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/554018 | Catheter lock solution formulations | Nov 24, 2014 | Issued |
Array
(
[id] => 11099573
[patent_doc_number] => 20160296544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'METHODS FOR PREVENTING OR MITIGATING ACUTE ALLERGIC RESPONSES USING HUMAN MILK OLIGOSACCHARIDES'
[patent_app_type] => utility
[patent_app_number] => 15/037743
[patent_app_country] => US
[patent_app_date] => 2014-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5997
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037743
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037743 | Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides | Nov 17, 2014 | Issued |
Array
(
[id] => 11082197
[patent_doc_number] => 20160279162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'MICELLE-BASED DELIVERY OF DERMAL THERAPEUTIC MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 15/037312
[patent_app_country] => US
[patent_app_date] => 2014-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12527
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037312
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037312 | MICELLE-BASED DELIVERY OF DERMAL THERAPEUTIC MATERIALS | Nov 17, 2014 | Abandoned |
Array
(
[id] => 11031606
[patent_doc_number] => 20160228562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'MUTUAL PRODRUG COMPRISING SHORT CHAIN FATTY ACIDS AND ZEBULARINE OR 1\'-CYANO-CYTARABINE FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/029852
[patent_app_country] => US
[patent_app_date] => 2014-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9664
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029852
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/029852 | Mutual prodrug comprising short chain fatty acids and zebularine or 1'-cyano-cytarabine for cancer treatment | Nov 13, 2014 | Issued |
Array
(
[id] => 11323784
[patent_doc_number] => 20160354395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'INFANT FORMULAS CONTAINING A 2-FUCOSYLATED OLIGOSACCHARIDE FOR TREATMENT OR PREVENTION OF INFLUENZA INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/036841
[patent_app_country] => US
[patent_app_date] => 2014-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9041
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036841
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036841 | INFANT FORMULAS CONTAINING A 2-FUCOSYLATED OLIGOSACCHARIDE FOR TREATMENT OR PREVENTION OF INFLUENZA INFECTION | Nov 13, 2014 | Abandoned |
Array
(
[id] => 11075767
[patent_doc_number] => 20160272731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'Chitin Nanocrystals and Process for Preparation Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/036080
[patent_app_country] => US
[patent_app_date] => 2014-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8776
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036080
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036080 | Chitin nanocrystals and process for preparation thereof | Nov 11, 2014 | Issued |
Array
(
[id] => 11083766
[patent_doc_number] => 20160280731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'CRYSTALLINE FORMS B, C, and D OF CANAGLIFLOZIN'
[patent_app_type] => utility
[patent_app_number] => 15/035751
[patent_app_country] => US
[patent_app_date] => 2014-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5244
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035751 | CRYSTALLINE FORMS B, C, and D OF CANAGLIFLOZIN | Nov 10, 2014 | Abandoned |
Array
(
[id] => 9910250
[patent_doc_number] => 20150065452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'ANTI-FATIGUE COMPOSITION, FORMULATION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/535257
[patent_app_country] => US
[patent_app_date] => 2014-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3239
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14535257
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/535257 | Anti-fatigue composition, formulation and use thereof | Nov 5, 2014 | Issued |
Array
(
[id] => 14031259
[patent_doc_number] => 10227368
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Generation of glucosamine from plant material
[patent_app_type] => utility
[patent_app_number] => 15/033736
[patent_app_country] => US
[patent_app_date] => 2014-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4123
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15033736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/033736 | Generation of glucosamine from plant material | Nov 4, 2014 | Issued |
Array
(
[id] => 11053283
[patent_doc_number] => 20160250245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'Methods and Pharmaceutical Composition for the Treatment of Polyomavirus Infections'
[patent_app_type] => utility
[patent_app_number] => 15/030416
[patent_app_country] => US
[patent_app_date] => 2014-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6108
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030416
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/030416 | Methods and Pharmaceutical Composition for the Treatment of Polyomavirus Infections | Oct 19, 2014 | Abandoned |
Array
(
[id] => 11060805
[patent_doc_number] => 20160257767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'Acylation Process'
[patent_app_type] => utility
[patent_app_number] => 15/029011
[patent_app_country] => US
[patent_app_date] => 2014-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10903
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029011
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/029011 | Acylation process | Oct 14, 2014 | Issued |
Array
(
[id] => 11060804
[patent_doc_number] => 20160257766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'Acylation Process'
[patent_app_type] => utility
[patent_app_number] => 15/029006
[patent_app_country] => US
[patent_app_date] => 2014-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9297
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029006
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/029006 | Acylation process | Oct 14, 2014 | Issued |
Array
(
[id] => 9858678
[patent_doc_number] => 20150038695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS AND EFFICIENT METHODS OF PREPARING THEM'
[patent_app_type] => utility
[patent_app_number] => 14/513855
[patent_app_country] => US
[patent_app_date] => 2014-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12953
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14513855
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/513855 | Regioselectively substituted cellulose esters and efficient methods of preparing them | Oct 13, 2014 | Issued |
Array
(
[id] => 11054510
[patent_doc_number] => 20160251470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'ZWITTERIONIC POLYSACCHARIDE POLYMERS HAVING ANTIFOULING, ANTIMICROBIAL AND OPTICAL TRANSPARENCY PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 15/028788
[patent_app_country] => US
[patent_app_date] => 2014-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24409
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15028788
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/028788 | ZWITTERIONIC POLYSACCHARIDE POLYMERS HAVING ANTIFOULING, ANTIMICROBIAL AND OPTICAL TRANSPARENCY PROPERTIES | Oct 13, 2014 | Abandoned |